3rd Circ. Sends J&J Remicade Antitrust Fight to Arbitration
By Matt Fair ( September 13, 2019, 6:18 PM EDT) -- The Third Circuit ruled on Friday that antitrust claims from Rochester Drug Cooperative Inc. over allegedly inflated prices it paid for the Johnson & Johnson immunosuppressant Remicade fell within the scope of an arbitration clause in a distribution agreement between the two companies....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.